Context: Back pain during pregnancy may be associated with deficits in physical functioning and disability. Research indicates that osteopathic manual treatment (OMT) slows the deterioration of back-specific functioning during pregnancy.
Methods
with ClinicalTrials.gov (NCT00298935), and its methodological details have been provided therein 17 and reported elsewhere. 15 The trial aimed to assess the efficacy of OMT delivered during the third trimester, as measured by an 11-point numerical rating scale (NRS) for typical level of back pain and the Roland-Morris Disability Questionnaire (RMDQ) 18 for back-specific functioning. Given the significant findings previously reported, 15 this updated assessment primarily focuses on using guidelines from the Cochrane Back Review Group to more clearly delineate the clinical relevance of OMT in preventing progressive back-specific dysfunction.
Patients without high-risk obstetric conditions were recruited and subsequently enrolled between weeks 28 and 30 of pregnancy. Blocked randomization according to age (⩽24 years vs ⩾25 years) and gravida status (primigravida vs multigravida) was used to assign patients to 16 We also computed the numbers needed to treat (NNTs) for prevention of back-specific dysfunction for UOBC+OMT relative to both comparator groups. The 95% CIs for NNTs were computed using the Wilson score method. 22 Finally, we conducted subgroup analyses by dichotomizing the baseline NRS scores for back pain and the RMDQ scores for back-specific functioning using a median split for each variable. The P value for interaction 23 was used to assess the risk of progressive back-specific dysfunction within the back pain and back-specific functioning subgroups. Data were managed and analyzed with the SPSS Statistics version 20 software (IBM Corporation). All study outcomes were assessed by intention-to-treat analysis with hypotheses tested at the .05 level of statistical significance using 2-tailed methods.
Results
The CONSORT diagram summarizing the flow of patients through the trial is presented in Figure 1 . The baseline characteristics of the 146 randomly assigned patients are presented in Table 1 . A total of 144 patients were in- Progressive back-specific dysfunction during the third trimester of pregnancy. Progressive back-specific dysfunction was defined as a 2-point or greater increase on the Roland-Morris Disability Questionnaire score during the third trimester. Abbreviations: OMT, osteopathic manual treatment; SUT, sham ultrasound therapy; UOBC, usual obstetric care.
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note that both trials computed NNT on the basis of absolute changes in the RMDQ score and both used the Wilson score method to compute the corresponding 95% CIs. In more practical terms, our NNT results suggest that for every 100 pregnant women who receive OMT to complement their UOBC during the third trimester, about 40 cases of progressive back-specific dysfunction would be prevented.
The previously reported study 15 results indicated that back pain decreased with UOBC+OMT, remained unchanged with UOBC+SUT, and increased with UOBC during the third trimester, although the results failed to achieve statistical significance.Unlike common "nonspecific" low back pain, the back pain experienced by pregnant women may be related to very specific changes that occur during the third trimester, including increased lumbar lordosis with pelvic tilt, increased thoracic kyphosis, and anterior tilt of the pelvic brim. 26 It is possible that the irreversible demands of advancing pregnancy, including fetal growth in length and weight, place a progressively increasing mechanical load on somatic tissues that evokes a nociceptive response that is resistant to analgesia. 27 Nevertheless, our present results suggest that . 25 While such between-trial comparisons of NNTs should be viewed cautiously, it is important to The risk ratios are for UOBC+OMT vs each control group based on intention-to-treat analyses. Risk ratios (RRs) less than 1 indicate some level of benefit with OMT in preventing progressive back-specific dysfunction. The effect size is based on the P value and RR, as interpreted using the Cochrane Back Review Group recommendations. 16 Using these criteria, treatment effects for prevention of progressive back-specific dysfunction that are statistically significant are further classified as small (RR>0.8), medium (0.5⩽RR⩽0.8), or large (RR<0.5).
Abbreviations: CI, confidence interval; NNT, number needed to treat; OMT, osteopathic manual treatment; SUT, sham ultrasound therapy; UOBC, usual obstetric care.
Conclusion
The present study indicates that OMT has a medium to large treatment effect in preventing progressive back- OMT may work by some mechanism to counter the factors that promote deficits in back-specific functioning during the third trimester. A recent study 28 ; however, these criteria generally focused on identifying thresholds for clinical improvement rather than deterioration. Because pregnant women are considered a vulnerable population, we elected to use the change score on the RMDQ that would be most sensitive in detecting progressive back-specific dysfunction.
Consequently, in line with the Editorial Board of the Cochrane Back Review Group, 21 we elected to use a 2-point or greater increase on the RMDQ during the third trimester as the criterion for progressive back-specific dysfunction. This change score corresponded to 30% deterioration for the typical patient in our study.
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